Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer

Fig. 5

FOXD3 hypermethylation suppresses ovarian cancer proliferation migration and apoptosis in vitro. ad The wound healing test indicated that FOXD3 over-expression group and 5-Aza-dC group significantly suppressed cell migration ability compared with control group, *p < 0.05. eh The colony formation results demonstrated that FOXD3 over-expression group and 5-Aza-dC group suppressed the level of SKOV3 and OV90 cells colony formation more obviously compared to control group, *p < 0.05

Back to article page